Trial Design Articles

Applied Clinical Trials: Feb 01, 2015
New study highlights the importance of focusing on non-core procedures to better optimize study design.
Applied Clinical Trials: Feb 01, 2015
Cancer Research UK applies risk-based monitoring across its entire trial portfolio. What were the results?
Applied Clinical Trials: Feb 01, 2015
Examining the design, implementation, and challenges of this direct-to-patient study model.
Applied Clinical Trials: Jan 22, 2015
Over recent years global drug companies large or small have recognized that one root cause of the high failure rate in their clinical development lies in the selection of right therapeutic targets.
Applied Clinical Trials: Jan 19, 2015
Case Study, Trigemina TI-001 for high frequency migraine
Applied Clinical Trials: Dec 01, 2014
Based on nearly 850 responses, a recent CISCRP study finds that the European public considers clinical research to be riskier than does the public in many other global regions.
Applied Clinical Trials: Sep 30, 2014
A systematic approach for early identification of BP effects during development of new drugs.
Applied Clinical Trials: Sep 30, 2014
Proving a biosimilar's pharmacokinetic 'equivalence' requires adherence to several unique factors.
Applied Clinical Trials: Sep 30, 2014
How modeling and simulation clarified complex exposure levels and an orphan drug got approved.
Applied Clinical Trials: Sep 30, 2014
Research shows that the potential of integrated alliances remains elusive in the near term.

Trial Design News

Annual ASCO Report Shows Widespread Disturbance in Oncology Practice

A new study by the American Society of Clinical Oncology (ASCO) is now available, which chronicles the current realities of the cancer care system and examines trends in the oncology workforce.

CRF Health's eCOA Solution for Diabetes Trials

CRF Health, the leading global provider of eCOA solutions for the life sciences industry, today announced a complete TrialMax® eCOA solution for diabetes clinical trials.

Intrinsic Imaging Awarded Interventional Medical Device Trial

Intrinsic Imaging is the only imaging core lab that is ISO 13485 certified specifically to provide quality services for medical device clinical trials.

ERT to Acquire PHT Corporation

ERT, a leading global solution provider for high- quality patient safety and efficacy endpoint data collection, and PHT Corporation (PHT), the eClinical innovator leading the adoption of patient-driven mobile apps for improved clinical research, announced today that they have signed a definitive agreement under which ERT will acquire PHT.

PHT Offers Rater Training in Three Instruments

The pharmaceutical industry is further optimizing the collection of high quality electronic patient reported outcomes (ePROs) data for clinical research, with PHT Corporation Rater Training programs